Jörn Weisner

11PUBLICATIONS
31CO-AUTHORS
Molecular targetsGene and molecular therapyPharmacogenomicsSignal transductionReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 06, 2026
Structure-based scaffold hopping reveals strategies to overcome oncogenic KIT and PDGFRA mutation-driven drug-resistance in GIST.

|May 14, 2025
Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation.

Suzanne Willems, Lejla Maksumic, Janina Niggenaber

|Apr 09, 2024
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises.

Kosmas Alexandros Pervanidis, Giovanni Danilo D'Angelo, Jörn Weisner

|Jan 03, 2024
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA.

A Teuber, T Schulz, B S Fletcher

|Feb 16, 2023
Insights into the Conformational Plasticity of the Protein Kinase Akt1 by Multi-Lateral Dipolar Spectroscopy.

Juliane Stehle, Jörn Weisner, Leanne Eichhorn

|Dec 22, 2022
A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2.

Shubhendu Palei, Jörn Weisner, Melina Vogt

Pageof 2

Frequent Collaborators

11 joint publications

Daniel Rauh

7 joint publications

Matthias P Müller

3 joint publications

Tom Schulz

3 joint publications

Jens T Siveke